LATEST NEWS
Alvogen Partially Acquires Lotus Pharma For US$200 Million
Lotus Pharmaceutical has signed a deal with US-based drug maker Alvogen Group Inc, allowing Alvogen to acquire 60 percent of its shares.
Takeda Submits New Drug Application For Fomepizole
Takeda has submitted an NDA to the Japanese Ministry of Health, Labor and Welfare for fomepizole, a treatment for ethylene glycol and methanol poisonings.
A*STAR, CM Engineering Develop Digital RF Technology
A*STAR and CM Engineering are collaborating to develop digital radio frequency technology to meet the demand for greater network coverage.
A*STAR, P&G Sign Five-Year Partnership
P&G and A*STAR have signed a five-year research partnership that provides the potential for up to S$60 million in joint funding
Takeda, MMV Partner To Study Anti-Malarial Compounds
Takeda Pharma will collaborate with Medicines for Malaria Venture to study two new anti-malarial compounds.
Chugai Opens Sales Office In China Medical City
Chugai has opened an import, sales and marketing subsidiary in China Medical City.
‘Brittle-Bone Babies’ Treated In The Womb With Stem Cells
Researchers have treated babies with congenital bone disease by injecting them with bone-forming stem cells while they were still in the womb.
Acupuncture Eases Breast Cancer Treatment Side Effects, Study
Breast cancer patients treated with an aromatase inhibitor experience fewer side effects when they get acupuncture, researchers say.
Daniel Hastings Appointed Director Of Singapore-MIT Alliance
Professor Daniel Hastings has been appointed as director of the Singapore-MIT Alliance for Research and Technology.
